title: In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia.
abstract: Non-dystrophic myotonias (NDMs) are caused by mutations in CLCN1 or SCN4A. The purpose of the present study was to optimize the genetic characterization of NDM in The Netherlands by analysing CLCN1 and SCN4A in tandem. All Dutch consultant neurologists and the Dutch Patient Association for Neuromuscular Diseases (Vereniging Spierziekten Nederland) were requested to refer patients with an initial diagnosis of NDM for clinical assessment and subsequent genetic analysis over a full year. Based on clinical criteria, sequencing of either CLCN1 or SCN4A was performed. When previously described mutations or novel mutations were identified in the first gene under study, the second gene was not sequenced. If no mutations were detected in the first gene, the second gene was subsequently also analysed. Underlying NDM mutations were explored in 54 families. In total, 20% (8 of 40) of our probands with suspected chloride channel myotonia showed no CLCN1 mutations but subsequent SCN4A screening revealed mutations in all of them. All 14 probands in whom SCN4A was primarily sequenced showed a mutation. In total, CLCN1 mutations were identified in 32 families (59%) and SCN4A in 22 (41%), resulting in a diagnostic yield of 100%. The yield of mutation detection was 93% with three recessive and three sporadic cases not yielding a second mutation. Among these mutations, 13 in CLCN1 and 3 in SCN4A were novel. In conclusion, the current results show that in tandem analysis of CLCN1 and SCN4A affords high-level mutation ascertainment in families with NDM.
authors.affiliation: Department of Neurology, University Hospital Maastricht, Maastricht, The Netherlands. jeroen.trip@wanadoo.nl
authors.forename: Jeroen
authors.initials: J
authors.lastname: Trip
authors.forename: Gea
authors.initials: G
authors.lastname: Drost
authors.forename: Dennis J
authors.initials: DJ
authors.lastname: Verbove
authors.forename: Anneke J
authors.initials: AJ
authors.lastname: van der Kooi
authors.forename: Jan B M
authors.initials: JB
authors.lastname: Kuks
authors.forename: Nicolette C
authors.initials: NC
authors.lastname: Notermans
authors.forename: Jan J
authors.initials: JJ
authors.lastname: Verschuuren
authors.forename: Marianne
authors.initials: M
authors.lastname: de Visser
authors.forename: Baziel G M
authors.initials: BG
authors.lastname: van Engelen
authors.forename: Carin G
authors.initials: CG
authors.lastname: Faber
authors.forename: Ieke B
authors.initials: IB
authors.lastname: Ginjaar
mesh_terms: D000328:Adult; D018118:Chloride Channels / Q000235:genetics*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005190:Family; D005260:Female; D005808:Genes, Recessive; D005820:Genetic Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009224:Myotonia Congenita / Q000175:diagnosis* / Q000235:genetics*; D062553:NAV1.4 Voltage-Gated Sodium Channel; D015222:Sodium Channels / Q000235:genetics*
chemical_list: C086321:CLC-1 channel; D018118:Chloride Channels; D062553:NAV1.4 Voltage-Gated Sodium Channel; C106251:SCN4A protein, human; D015222:Sodium Channels